Vimarsana
Biggest News Aggregation in the World

Page 4 - Rose Weldon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rose Weldon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rose Weldon Today - Breaking & Trending Today

Cullinan Oncology Reports Inducement Grants Under Nasdaq - Vimarsana News

Cullinan Oncology Reports Inducement Grants Under Nasdaq

CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...

Cullinan Oncology Reports Inducement Grants Under Nasdaq - Vimarsana News

Cullinan Oncology Reports Inducement Grants Under Nasdaq

CAMBRIDGE, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...

Q&A: What pediatricians should expect of AFM, other adenoviruses - Vimarsana News

Q&A: What pediatricians should expect of AFM, other adenoviruses

With the CDC suggesting that adenovirus should be considered in diagnosis of acute hepatitis in children, amidst a possible outbreak of cases in Europe and the U.S., some pediatricians are wondering what to look out for in their own practices.

Source: healio.com
First RCT evaluates safety, efficacy of furosemide in preemies with BPD risk - Vimarsana News

First RCT evaluates safety, efficacy of furosemide in preemies with BPD risk

DENVER — The first randomized controlled trial of furosemide for preterm infants at high risk for bronchopulmonary dysplasia found an increased risk for electrolyte adverse events but no greater risk for overall safety events.

Source: healio.com
No mortality benefit of early ibuprofen in preterm infants with arteriosus - Vimarsana News

No mortality benefit of early ibuprofen in preterm infants with arteriosus

DENVER — A randomized controlled trial found that early targeted treatment with ibuprofen did not reduce mortality among 72-hour-old extremely preterm infants with a large patent ductus arteriosus, researchers reported here.

Source: healio.com